Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Gene Cell Therapy CDMO market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Gene Cell Therapy CDMO Industry Forecast” looks at past sales and reviews total world Gene Cell Therapy CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Cell Therapy CDMO sales for 2023 through 2029. With Gene Cell Therapy CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Cell Therapy CDMO industry.
This Insight Report provides a comprehensive analysis of the global Gene Cell Therapy CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Cell Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Cell Therapy CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Cell Therapy CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Cell Therapy CDMO.
United States market for Gene Cell Therapy CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Gene Cell Therapy CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Gene Cell Therapy CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Gene Cell Therapy CDMO players cover Catalent, Lonza, Thermo Fisher, ACG Biologics, Charles River, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Cell Therapy CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Gene Cell Therapy CDMO market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Gene Cell Therapy CDMO Industry Forecast” looks at past sales and reviews total world Gene Cell Therapy CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Cell Therapy CDMO sales for 2023 through 2029. With Gene Cell Therapy CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Cell Therapy CDMO industry.
This Insight Report provides a comprehensive analysis of the global Gene Cell Therapy CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Cell Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Cell Therapy CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Cell Therapy CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Cell Therapy CDMO.
United States market for Gene Cell Therapy CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Gene Cell Therapy CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Gene Cell Therapy CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Gene Cell Therapy CDMO players cover Catalent, Lonza, Thermo Fisher, ACG Biologics, Charles River, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Cell Therapy CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Immune Cells
- Stem Cell
- Viral Vector
- Plasmid DNA
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutions
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Immune Cells
- Stem Cell
- Viral Vector
- Plasmid DNA
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutions
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Catalent
- Lonza
- Thermo Fisher
- ACG Biologics
- Charles River
- Oxford Biomedica
- Novartis
- OBiO
- GenScript
- Pharmaron
- Porton
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Cell Therapy CDMO Market Size 2019-2030
2.1.2 Gene Cell Therapy CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Gene Cell Therapy CDMO by Country/Region, 2019, 2023 & 2030
2.2 Gene Cell Therapy CDMO Segment by Type
2.2.1 Immune Cells
2.2.2 Stem Cell
2.2.3 Viral Vector
2.2.4 Plasmid DNA
2.3 Gene Cell Therapy CDMO Market Size by Type
2.3.1 Gene Cell Therapy CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
2.4 Gene Cell Therapy CDMO Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Research and Academic Institutions
2.4.3 Hospital
2.4.4 Others
2.5 Gene Cell Therapy CDMO Market Size by Application
2.5.1 Gene Cell Therapy CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024)
3 GENE CELL THERAPY CDMO MARKET SIZE BY PLAYER
3.1 Gene Cell Therapy CDMO Market Size Market Share by Player
3.1.1 Global Gene Cell Therapy CDMO Revenue by Player (2019-2024)
3.1.2 Global Gene Cell Therapy CDMO Revenue Market Share by Player (2019-2024)
3.2 Global Gene Cell Therapy CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE CELL THERAPY CDMO BY REGION
4.1 Gene Cell Therapy CDMO Market Size by Region (2019-2024)
4.2 Global Gene Cell Therapy CDMO Annual Revenue by Country/Region (2019-2024)
4.3 Americas Gene Cell Therapy CDMO Market Size Growth (2019-2024)
4.4 APAC Gene Cell Therapy CDMO Market Size Growth (2019-2024)
4.5 Europe Gene Cell Therapy CDMO Market Size Growth (2019-2024)
4.6 Middle East & Africa Gene Cell Therapy CDMO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Gene Cell Therapy CDMO Market Size by Country (2019-2024)
5.2 Americas Gene Cell Therapy CDMO Market Size by Type (2019-2024)
5.3 Americas Gene Cell Therapy CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Cell Therapy CDMO Market Size by Region (2019-2024)
6.2 APAC Gene Cell Therapy CDMO Market Size by Type (2019-2024)
6.3 APAC Gene Cell Therapy CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Cell Therapy CDMO Market Size by Country (2019-2024)
7.2 Europe Gene Cell Therapy CDMO Market Size by Type (2019-2024)
7.3 Europe Gene Cell Therapy CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Cell Therapy CDMO by Region (2019-2024)
8.2 Middle East & Africa Gene Cell Therapy CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Gene Cell Therapy CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE CELL THERAPY CDMO MARKET FORECAST
10.1 Global Gene Cell Therapy CDMO Forecast by Region (2025-2030)
10.1.1 Global Gene Cell Therapy CDMO Forecast by Region (2025-2030)
10.1.2 Americas Gene Cell Therapy CDMO Forecast
10.1.3 APAC Gene Cell Therapy CDMO Forecast
10.1.4 Europe Gene Cell Therapy CDMO Forecast
10.1.5 Middle East & Africa Gene Cell Therapy CDMO Forecast
10.2 Americas Gene Cell Therapy CDMO Forecast by Country (2025-2030)
10.2.1 United States Market Gene Cell Therapy CDMO Forecast
10.2.2 Canada Market Gene Cell Therapy CDMO Forecast
10.2.3 Mexico Market Gene Cell Therapy CDMO Forecast
10.2.4 Brazil Market Gene Cell Therapy CDMO Forecast
10.3 APAC Gene Cell Therapy CDMO Forecast by Region (2025-2030)
10.3.1 China Gene Cell Therapy CDMO Market Forecast
10.3.2 Japan Market Gene Cell Therapy CDMO Forecast
10.3.3 Korea Market Gene Cell Therapy CDMO Forecast
10.3.4 Southeast Asia Market Gene Cell Therapy CDMO Forecast
10.3.5 India Market Gene Cell Therapy CDMO Forecast
10.3.6 Australia Market Gene Cell Therapy CDMO Forecast
10.4 Europe Gene Cell Therapy CDMO Forecast by Country (2025-2030)
10.4.1 Germany Market Gene Cell Therapy CDMO Forecast
10.4.2 France Market Gene Cell Therapy CDMO Forecast
10.4.3 UK Market Gene Cell Therapy CDMO Forecast
10.4.4 Italy Market Gene Cell Therapy CDMO Forecast
10.4.5 Russia Market Gene Cell Therapy CDMO Forecast
10.5 Middle East & Africa Gene Cell Therapy CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Market Gene Cell Therapy CDMO Forecast
10.5.2 South Africa Market Gene Cell Therapy CDMO Forecast
10.5.3 Israel Market Gene Cell Therapy CDMO Forecast
10.5.4 Turkey Market Gene Cell Therapy CDMO Forecast
10.6 Global Gene Cell Therapy CDMO Forecast by Type (2025-2030)
10.7 Global Gene Cell Therapy CDMO Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Gene Cell Therapy CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Catalent
11.1.1 Catalent Company Information
11.1.2 Catalent Gene Cell Therapy CDMO Product Offered
11.1.3 Catalent Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Catalent Main Business Overview
11.1.5 Catalent Latest Developments
11.2 Lonza
11.2.1 Lonza Company Information
11.2.2 Lonza Gene Cell Therapy CDMO Product Offered
11.2.3 Lonza Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Lonza Main Business Overview
11.2.5 Lonza Latest Developments
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Information
11.3.2 Thermo Fisher Gene Cell Therapy CDMO Product Offered
11.3.3 Thermo Fisher Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Main Business Overview
11.3.5 Thermo Fisher Latest Developments
11.4 ACG Biologics
11.4.1 ACG Biologics Company Information
11.4.2 ACG Biologics Gene Cell Therapy CDMO Product Offered
11.4.3 ACG Biologics Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 ACG Biologics Main Business Overview
11.4.5 ACG Biologics Latest Developments
11.5 Charles River
11.5.1 Charles River Company Information
11.5.2 Charles River Gene Cell Therapy CDMO Product Offered
11.5.3 Charles River Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Charles River Main Business Overview
11.5.5 Charles River Latest Developments
11.6 Oxford Biomedica
11.6.1 Oxford Biomedica Company Information
11.6.2 Oxford Biomedica Gene Cell Therapy CDMO Product Offered
11.6.3 Oxford Biomedica Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Oxford Biomedica Main Business Overview
11.6.5 Oxford Biomedica Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Gene Cell Therapy CDMO Product Offered
11.7.3 Novartis Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 OBiO
11.8.1 OBiO Company Information
11.8.2 OBiO Gene Cell Therapy CDMO Product Offered
11.8.3 OBiO Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 OBiO Main Business Overview
11.8.5 OBiO Latest Developments
11.9 GenScript
11.9.1 GenScript Company Information
11.9.2 GenScript Gene Cell Therapy CDMO Product Offered
11.9.3 GenScript Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GenScript Main Business Overview
11.9.5 GenScript Latest Developments
11.10 Pharmaron
11.10.1 Pharmaron Company Information
11.10.2 Pharmaron Gene Cell Therapy CDMO Product Offered
11.10.3 Pharmaron Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Pharmaron Main Business Overview
11.10.5 Pharmaron Latest Developments
11.11 Porton
11.11.1 Porton Company Information
11.11.2 Porton Gene Cell Therapy CDMO Product Offered
11.11.3 Porton Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Porton Main Business Overview
11.11.5 Porton Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Cell Therapy CDMO Market Size 2019-2030
2.1.2 Gene Cell Therapy CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Gene Cell Therapy CDMO by Country/Region, 2019, 2023 & 2030
2.2 Gene Cell Therapy CDMO Segment by Type
2.2.1 Immune Cells
2.2.2 Stem Cell
2.2.3 Viral Vector
2.2.4 Plasmid DNA
2.3 Gene Cell Therapy CDMO Market Size by Type
2.3.1 Gene Cell Therapy CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
2.4 Gene Cell Therapy CDMO Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Research and Academic Institutions
2.4.3 Hospital
2.4.4 Others
2.5 Gene Cell Therapy CDMO Market Size by Application
2.5.1 Gene Cell Therapy CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024)
3 GENE CELL THERAPY CDMO MARKET SIZE BY PLAYER
3.1 Gene Cell Therapy CDMO Market Size Market Share by Player
3.1.1 Global Gene Cell Therapy CDMO Revenue by Player (2019-2024)
3.1.2 Global Gene Cell Therapy CDMO Revenue Market Share by Player (2019-2024)
3.2 Global Gene Cell Therapy CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE CELL THERAPY CDMO BY REGION
4.1 Gene Cell Therapy CDMO Market Size by Region (2019-2024)
4.2 Global Gene Cell Therapy CDMO Annual Revenue by Country/Region (2019-2024)
4.3 Americas Gene Cell Therapy CDMO Market Size Growth (2019-2024)
4.4 APAC Gene Cell Therapy CDMO Market Size Growth (2019-2024)
4.5 Europe Gene Cell Therapy CDMO Market Size Growth (2019-2024)
4.6 Middle East & Africa Gene Cell Therapy CDMO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Gene Cell Therapy CDMO Market Size by Country (2019-2024)
5.2 Americas Gene Cell Therapy CDMO Market Size by Type (2019-2024)
5.3 Americas Gene Cell Therapy CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Cell Therapy CDMO Market Size by Region (2019-2024)
6.2 APAC Gene Cell Therapy CDMO Market Size by Type (2019-2024)
6.3 APAC Gene Cell Therapy CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Cell Therapy CDMO Market Size by Country (2019-2024)
7.2 Europe Gene Cell Therapy CDMO Market Size by Type (2019-2024)
7.3 Europe Gene Cell Therapy CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Cell Therapy CDMO by Region (2019-2024)
8.2 Middle East & Africa Gene Cell Therapy CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Gene Cell Therapy CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE CELL THERAPY CDMO MARKET FORECAST
10.1 Global Gene Cell Therapy CDMO Forecast by Region (2025-2030)
10.1.1 Global Gene Cell Therapy CDMO Forecast by Region (2025-2030)
10.1.2 Americas Gene Cell Therapy CDMO Forecast
10.1.3 APAC Gene Cell Therapy CDMO Forecast
10.1.4 Europe Gene Cell Therapy CDMO Forecast
10.1.5 Middle East & Africa Gene Cell Therapy CDMO Forecast
10.2 Americas Gene Cell Therapy CDMO Forecast by Country (2025-2030)
10.2.1 United States Market Gene Cell Therapy CDMO Forecast
10.2.2 Canada Market Gene Cell Therapy CDMO Forecast
10.2.3 Mexico Market Gene Cell Therapy CDMO Forecast
10.2.4 Brazil Market Gene Cell Therapy CDMO Forecast
10.3 APAC Gene Cell Therapy CDMO Forecast by Region (2025-2030)
10.3.1 China Gene Cell Therapy CDMO Market Forecast
10.3.2 Japan Market Gene Cell Therapy CDMO Forecast
10.3.3 Korea Market Gene Cell Therapy CDMO Forecast
10.3.4 Southeast Asia Market Gene Cell Therapy CDMO Forecast
10.3.5 India Market Gene Cell Therapy CDMO Forecast
10.3.6 Australia Market Gene Cell Therapy CDMO Forecast
10.4 Europe Gene Cell Therapy CDMO Forecast by Country (2025-2030)
10.4.1 Germany Market Gene Cell Therapy CDMO Forecast
10.4.2 France Market Gene Cell Therapy CDMO Forecast
10.4.3 UK Market Gene Cell Therapy CDMO Forecast
10.4.4 Italy Market Gene Cell Therapy CDMO Forecast
10.4.5 Russia Market Gene Cell Therapy CDMO Forecast
10.5 Middle East & Africa Gene Cell Therapy CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Market Gene Cell Therapy CDMO Forecast
10.5.2 South Africa Market Gene Cell Therapy CDMO Forecast
10.5.3 Israel Market Gene Cell Therapy CDMO Forecast
10.5.4 Turkey Market Gene Cell Therapy CDMO Forecast
10.6 Global Gene Cell Therapy CDMO Forecast by Type (2025-2030)
10.7 Global Gene Cell Therapy CDMO Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Gene Cell Therapy CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Catalent
11.1.1 Catalent Company Information
11.1.2 Catalent Gene Cell Therapy CDMO Product Offered
11.1.3 Catalent Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Catalent Main Business Overview
11.1.5 Catalent Latest Developments
11.2 Lonza
11.2.1 Lonza Company Information
11.2.2 Lonza Gene Cell Therapy CDMO Product Offered
11.2.3 Lonza Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Lonza Main Business Overview
11.2.5 Lonza Latest Developments
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Information
11.3.2 Thermo Fisher Gene Cell Therapy CDMO Product Offered
11.3.3 Thermo Fisher Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Main Business Overview
11.3.5 Thermo Fisher Latest Developments
11.4 ACG Biologics
11.4.1 ACG Biologics Company Information
11.4.2 ACG Biologics Gene Cell Therapy CDMO Product Offered
11.4.3 ACG Biologics Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 ACG Biologics Main Business Overview
11.4.5 ACG Biologics Latest Developments
11.5 Charles River
11.5.1 Charles River Company Information
11.5.2 Charles River Gene Cell Therapy CDMO Product Offered
11.5.3 Charles River Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Charles River Main Business Overview
11.5.5 Charles River Latest Developments
11.6 Oxford Biomedica
11.6.1 Oxford Biomedica Company Information
11.6.2 Oxford Biomedica Gene Cell Therapy CDMO Product Offered
11.6.3 Oxford Biomedica Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Oxford Biomedica Main Business Overview
11.6.5 Oxford Biomedica Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Gene Cell Therapy CDMO Product Offered
11.7.3 Novartis Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 OBiO
11.8.1 OBiO Company Information
11.8.2 OBiO Gene Cell Therapy CDMO Product Offered
11.8.3 OBiO Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 OBiO Main Business Overview
11.8.5 OBiO Latest Developments
11.9 GenScript
11.9.1 GenScript Company Information
11.9.2 GenScript Gene Cell Therapy CDMO Product Offered
11.9.3 GenScript Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GenScript Main Business Overview
11.9.5 GenScript Latest Developments
11.10 Pharmaron
11.10.1 Pharmaron Company Information
11.10.2 Pharmaron Gene Cell Therapy CDMO Product Offered
11.10.3 Pharmaron Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Pharmaron Main Business Overview
11.10.5 Pharmaron Latest Developments
11.11 Porton
11.11.1 Porton Company Information
11.11.2 Porton Gene Cell Therapy CDMO Product Offered
11.11.3 Porton Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Porton Main Business Overview
11.11.5 Porton Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Cell Therapy CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Gene Cell Therapy CDMO Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Immune Cells
Table 4. Major Players of Stem Cell
Table 5. Major Players of Viral Vector
Table 6. Major Players of Plasmid DNA
Table 7. Gene Cell Therapy CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
Table 10. Gene Cell Therapy CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024)
Table 13. Global Gene Cell Therapy CDMO Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Gene Cell Therapy CDMO Revenue Market Share by Player (2019-2024)
Table 15. Gene Cell Therapy CDMO Key Players Head office and Products Offered
Table 16. Gene Cell Therapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Gene Cell Therapy CDMO Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Gene Cell Therapy CDMO Market Size Market Share by Region (2019-2024)
Table 21. Global Gene Cell Therapy CDMO Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Gene Cell Therapy CDMO Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Gene Cell Therapy CDMO Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Gene Cell Therapy CDMO Market Size Market Share by Country (2019-2024)
Table 25. Americas Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
Table 27. Americas Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024)
Table 29. APAC Gene Cell Therapy CDMO Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Gene Cell Therapy CDMO Market Size Market Share by Region (2019-2024)
Table 31. APAC Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Gene Cell Therapy CDMO Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Gene Cell Therapy CDMO Market Size Market Share by Country (2019-2024)
Table 35. Europe Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Gene Cell Therapy CDMO Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Gene Cell Therapy CDMO
Table 41. Key Market Challenges & Risks of Gene Cell Therapy CDMO
Table 42. Key Industry Trends of Gene Cell Therapy CDMO
Table 43. Global Gene Cell Therapy CDMO Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Gene Cell Therapy CDMO Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Gene Cell Therapy CDMO Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Gene Cell Therapy CDMO Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. Catalent Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 48. Catalent Gene Cell Therapy CDMO Product Offered
Table 49. Catalent Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Catalent Main Business
Table 51. Catalent Latest Developments
Table 52. Lonza Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 53. Lonza Gene Cell Therapy CDMO Product Offered
Table 54. Lonza Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Lonza Main Business
Table 56. Lonza Latest Developments
Table 57. Thermo Fisher Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 58. Thermo Fisher Gene Cell Therapy CDMO Product Offered
Table 59. Thermo Fisher Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Thermo Fisher Main Business
Table 61. Thermo Fisher Latest Developments
Table 62. ACG Biologics Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 63. ACG Biologics Gene Cell Therapy CDMO Product Offered
Table 64. ACG Biologics Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. ACG Biologics Main Business
Table 66. ACG Biologics Latest Developments
Table 67. Charles River Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 68. Charles River Gene Cell Therapy CDMO Product Offered
Table 69. Charles River Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Charles River Main Business
Table 71. Charles River Latest Developments
Table 72. Oxford Biomedica Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 73. Oxford Biomedica Gene Cell Therapy CDMO Product Offered
Table 74. Oxford Biomedica Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Oxford Biomedica Main Business
Table 76. Oxford Biomedica Latest Developments
Table 77. Novartis Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 78. Novartis Gene Cell Therapy CDMO Product Offered
Table 79. Novartis Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. OBiO Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 83. OBiO Gene Cell Therapy CDMO Product Offered
Table 84. OBiO Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. OBiO Main Business
Table 86. OBiO Latest Developments
Table 87. GenScript Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 88. GenScript Gene Cell Therapy CDMO Product Offered
Table 89. GenScript Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. GenScript Main Business
Table 91. GenScript Latest Developments
Table 92. Pharmaron Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 93. Pharmaron Gene Cell Therapy CDMO Product Offered
Table 94. Pharmaron Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Pharmaron Main Business
Table 96. Pharmaron Latest Developments
Table 97. Porton Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 98. Porton Gene Cell Therapy CDMO Product Offered
Table 99. Porton Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Porton Main Business
Table 101. Porton Latest Developments
Table 1. Gene Cell Therapy CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Gene Cell Therapy CDMO Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Immune Cells
Table 4. Major Players of Stem Cell
Table 5. Major Players of Viral Vector
Table 6. Major Players of Plasmid DNA
Table 7. Gene Cell Therapy CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
Table 10. Gene Cell Therapy CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024)
Table 13. Global Gene Cell Therapy CDMO Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Gene Cell Therapy CDMO Revenue Market Share by Player (2019-2024)
Table 15. Gene Cell Therapy CDMO Key Players Head office and Products Offered
Table 16. Gene Cell Therapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Gene Cell Therapy CDMO Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Gene Cell Therapy CDMO Market Size Market Share by Region (2019-2024)
Table 21. Global Gene Cell Therapy CDMO Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Gene Cell Therapy CDMO Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Gene Cell Therapy CDMO Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Gene Cell Therapy CDMO Market Size Market Share by Country (2019-2024)
Table 25. Americas Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
Table 27. Americas Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024)
Table 29. APAC Gene Cell Therapy CDMO Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Gene Cell Therapy CDMO Market Size Market Share by Region (2019-2024)
Table 31. APAC Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Gene Cell Therapy CDMO Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Gene Cell Therapy CDMO Market Size Market Share by Country (2019-2024)
Table 35. Europe Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Gene Cell Therapy CDMO Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Gene Cell Therapy CDMO
Table 41. Key Market Challenges & Risks of Gene Cell Therapy CDMO
Table 42. Key Industry Trends of Gene Cell Therapy CDMO
Table 43. Global Gene Cell Therapy CDMO Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Gene Cell Therapy CDMO Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Gene Cell Therapy CDMO Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Gene Cell Therapy CDMO Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. Catalent Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 48. Catalent Gene Cell Therapy CDMO Product Offered
Table 49. Catalent Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Catalent Main Business
Table 51. Catalent Latest Developments
Table 52. Lonza Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 53. Lonza Gene Cell Therapy CDMO Product Offered
Table 54. Lonza Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Lonza Main Business
Table 56. Lonza Latest Developments
Table 57. Thermo Fisher Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 58. Thermo Fisher Gene Cell Therapy CDMO Product Offered
Table 59. Thermo Fisher Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Thermo Fisher Main Business
Table 61. Thermo Fisher Latest Developments
Table 62. ACG Biologics Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 63. ACG Biologics Gene Cell Therapy CDMO Product Offered
Table 64. ACG Biologics Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. ACG Biologics Main Business
Table 66. ACG Biologics Latest Developments
Table 67. Charles River Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 68. Charles River Gene Cell Therapy CDMO Product Offered
Table 69. Charles River Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Charles River Main Business
Table 71. Charles River Latest Developments
Table 72. Oxford Biomedica Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 73. Oxford Biomedica Gene Cell Therapy CDMO Product Offered
Table 74. Oxford Biomedica Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Oxford Biomedica Main Business
Table 76. Oxford Biomedica Latest Developments
Table 77. Novartis Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 78. Novartis Gene Cell Therapy CDMO Product Offered
Table 79. Novartis Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. OBiO Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 83. OBiO Gene Cell Therapy CDMO Product Offered
Table 84. OBiO Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. OBiO Main Business
Table 86. OBiO Latest Developments
Table 87. GenScript Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 88. GenScript Gene Cell Therapy CDMO Product Offered
Table 89. GenScript Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. GenScript Main Business
Table 91. GenScript Latest Developments
Table 92. Pharmaron Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 93. Pharmaron Gene Cell Therapy CDMO Product Offered
Table 94. Pharmaron Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Pharmaron Main Business
Table 96. Pharmaron Latest Developments
Table 97. Porton Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors
Table 98. Porton Gene Cell Therapy CDMO Product Offered
Table 99. Porton Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Porton Main Business
Table 101. Porton Latest Developments
LIST OF FIGURES
Figure 1. Gene Cell Therapy CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Cell Therapy CDMO Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Gene Cell Therapy CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Gene Cell Therapy CDMO Sales Market Share by Country/Region (2023)
Figure 8. Gene Cell Therapy CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Gene Cell Therapy CDMO Market Size Market Share by Type in 2023
Figure 10. Gene Cell Therapy CDMO in Pharmaceutical and Biotechnology Companies
Figure 11. Global Gene Cell Therapy CDMO Market: Pharmaceutical and Biotechnology Companies (2019-2024) & ($ millions)
Figure 12. Gene Cell Therapy CDMO in Research and Academic Institutions
Figure 13. Global Gene Cell Therapy CDMO Market: Research and Academic Institutions (2019-2024) & ($ millions)
Figure 14. Gene Cell Therapy CDMO in Hospital
Figure 15. Global Gene Cell Therapy CDMO Market: Hospital (2019-2024) & ($ millions)
Figure 16. Gene Cell Therapy CDMO in Others
Figure 17. Global Gene Cell Therapy CDMO Market: Others (2019-2024) & ($ millions)
Figure 18. Global Gene Cell Therapy CDMO Market Size Market Share by Application in 2023
Figure 19. Global Gene Cell Therapy CDMO Revenue Market Share by Player in 2023
Figure 20. Global Gene Cell Therapy CDMO Market Size Market Share by Region (2019-2024)
Figure 21. Americas Gene Cell Therapy CDMO Market Size 2019-2024 ($ millions)
Figure 22. APAC Gene Cell Therapy CDMO Market Size 2019-2024 ($ millions)
Figure 23. Europe Gene Cell Therapy CDMO Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Gene Cell Therapy CDMO Market Size 2019-2024 ($ millions)
Figure 25. Americas Gene Cell Therapy CDMO Value Market Share by Country in 2023
Figure 26. United States Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Gene Cell Therapy CDMO Market Size Market Share by Region in 2023
Figure 31. APAC Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
Figure 32. APAC Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024)
Figure 33. China Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 37. India Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Gene Cell Therapy CDMO Market Size Market Share by Country in 2023
Figure 40. Europe Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
Figure 41. Europe Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024)
Figure 42. Germany Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 43. France Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Gene Cell Therapy CDMO Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 56. APAC Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 57. Europe Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 59. United States Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 60. Canada Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 61. Mexico Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 62. Brazil Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 63. China Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 64. Japan Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 65. Korea Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 67. India Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 68. Australia Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 69. Germany Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 70. France Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 71. UK Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 72. Italy Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 73. Russia Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 74. Egypt Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 75. South Africa Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 76. Israel Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 77. Turkey Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 79. Global Gene Cell Therapy CDMO Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Gene Cell Therapy CDMO Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Gene Cell Therapy CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Cell Therapy CDMO Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Gene Cell Therapy CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Gene Cell Therapy CDMO Sales Market Share by Country/Region (2023)
Figure 8. Gene Cell Therapy CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Gene Cell Therapy CDMO Market Size Market Share by Type in 2023
Figure 10. Gene Cell Therapy CDMO in Pharmaceutical and Biotechnology Companies
Figure 11. Global Gene Cell Therapy CDMO Market: Pharmaceutical and Biotechnology Companies (2019-2024) & ($ millions)
Figure 12. Gene Cell Therapy CDMO in Research and Academic Institutions
Figure 13. Global Gene Cell Therapy CDMO Market: Research and Academic Institutions (2019-2024) & ($ millions)
Figure 14. Gene Cell Therapy CDMO in Hospital
Figure 15. Global Gene Cell Therapy CDMO Market: Hospital (2019-2024) & ($ millions)
Figure 16. Gene Cell Therapy CDMO in Others
Figure 17. Global Gene Cell Therapy CDMO Market: Others (2019-2024) & ($ millions)
Figure 18. Global Gene Cell Therapy CDMO Market Size Market Share by Application in 2023
Figure 19. Global Gene Cell Therapy CDMO Revenue Market Share by Player in 2023
Figure 20. Global Gene Cell Therapy CDMO Market Size Market Share by Region (2019-2024)
Figure 21. Americas Gene Cell Therapy CDMO Market Size 2019-2024 ($ millions)
Figure 22. APAC Gene Cell Therapy CDMO Market Size 2019-2024 ($ millions)
Figure 23. Europe Gene Cell Therapy CDMO Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Gene Cell Therapy CDMO Market Size 2019-2024 ($ millions)
Figure 25. Americas Gene Cell Therapy CDMO Value Market Share by Country in 2023
Figure 26. United States Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Gene Cell Therapy CDMO Market Size Market Share by Region in 2023
Figure 31. APAC Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
Figure 32. APAC Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024)
Figure 33. China Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 37. India Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Gene Cell Therapy CDMO Market Size Market Share by Country in 2023
Figure 40. Europe Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
Figure 41. Europe Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024)
Figure 42. Germany Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 43. France Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Gene Cell Therapy CDMO Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 56. APAC Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 57. Europe Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 59. United States Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 60. Canada Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 61. Mexico Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 62. Brazil Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 63. China Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 64. Japan Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 65. Korea Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 67. India Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 68. Australia Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 69. Germany Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 70. France Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 71. UK Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 72. Italy Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 73. Russia Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 74. Egypt Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 75. South Africa Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 76. Israel Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 77. Turkey Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions)
Figure 79. Global Gene Cell Therapy CDMO Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Gene Cell Therapy CDMO Market Size Market Share Forecast by Application (2025-2030)
